Company intelligence / Profile preview

Aliker Nexgen Therapeutics

Lucknow, Uttar Pradesh, India

Ownership: Private
Development stage: Other

Overview

Aliker Nexgen Therapeutics is a biotechnology company focused on the discovery and development of novel therapeutic agents for oncology and infectious diseases. The company leverages advanced medicinal chemistry and drug design to create small molecule candidates aimed at addressing unmet medical needs. Based in India, Aliker Nexgen operates primarily in the early stages of drug development, focusing on identifying potent leads for further clinical evaluation. Their business model emphasizes research and development to build a robust pipeline of proprietary pharmaceutical assets.

Therapeutic areas: Infectious DiseasesOncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Aliker Nexgen Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aliker Nexgen Therapeutics.

Explore the full profile